Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Including medical news, pharmaceutical industry news, new drug approvals, applications and clinical trial results.

Daily MedNews

Here are some of the latest health and medical news developments, compiled by editors of HealthDay: Salmonella Reported in Frozen Chicken Dinners Details were sketchy Sunday, but the U.S. Department of Agriculture has issued an alert concerning 32...
Here are some of the latest health and medical news developments, compiled by editors of HealthDay: Norovirus Outbreak Strikes Georgetown University More than 170 Georgetown University students in Washington D.C. have become ill from a norovirus...
MONDAY, Oct. 6 -- Exposing your children to the joys of pet ownership may, in some cases, also mean exposing them to infections and injuries. Parents need to be aware of the dangers -- including salmonella infection and even monkey pox -- of owning...
MONDAY, Oct. 6 -- Free prescription drug samples distributed to pediatric patients may be unsafe, research suggests. The study, published in the October 2008 issue of Pediatrics, examined data on 10,295 children and adolescents from the 2004 Medical...
-- Proper supervision and wearing protective gear, especially a helmet, are critical to biking safely. The Nemours Foundation offers these safety tips for children to prevent biking accidents: Wear fluorescent, brightly-colored or reflective...

More...

Pharma Industry News

Court Also Upholds Validity of Patent Claim in TKT and Aventis Litigation THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Amgen (NASDAQ:AMGN) announced today that the United States (U.S.) District Court in Boston issued its written decision upholding the...
WASHINGTON, Oct. 2 /PRNewswire-USNewswire/ -- Cardinal Health Inc., one of the nation's largest distributors of pharmaceutical drugs, has agreed to settle allegations that it violated federal reporting provisions relating to its handling of certain...
Company expects to resume shipments of controlled substances from its Auburn, Wash., Lakeland, Fla. and Swedesboro, N.J. distribution facilities by end of November   DUBLIN, Ohio, Oct. 2 /PRNewswire-FirstCall/ -- Cardinal Health, a global...
GENEVA, Switzerland, October 2/PRNewswire/ -- Merck Serono, a division of Merck KGaA, Darmstadt, Germany, announced today that Genentech Inc. has reported a case of progressive multifocal leukoencephalopathy (PML) in a 70-year old patient who had...
SOUTH SAN FRANCISCO, Calif.  --  October 2, 2008 --  Genentech, Inc. (NYSE: DNA) announced today that the company has issued a Dear Healthcare Provider letter to inform potential prescribers of a case of progressive multifocal...

More...

New Drug Approvals

PRINCETON, N.J., Oct. 1, 2008-- BUSINESS WIRE --Bristol-Myers Squibb Company announced today that the U.S. Food & Drug Administration (FDA) approved the use of Reyataz (atazanavir sulfate) 300 mg once-daily boosted with ritonavir 100 mg as part of...
INDIANAPOLIS, Sept. 29 /PRNewswire-FirstCall/ -- Eli Lilly and Company announced today it received approval from the U.S. Food and Drug Administration (FDA) for the use of Alimta (pemetrexed for injection), in combination with cisplatin, in the...
Company also announces FDA approval of TAXUS Express2 Stent System for treatment of in-stent restenosis NATICK, Mass., September 25, 2008 /PRNewswire-FirstCall/ -- Boston Scientific Corporation today announced that it has received approval from the...
JERUSALEM--(BUSINESS WIRE)--Sept. 23, 2008 - Teva Pharmaceutical Industries Ltd. today announced that the U.S. Food and Drug Administration (FDA) has approved ProAir HFA (albuterol sulfate) Inhalation Aerosol for use in patients as young as 4 years...
BRIDGEWATER, N.J., September 23, 2008 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today the U.S. Food and Drug Administration (FDA) has approved Nasacort AQ Nasal Spray (triamcinolone acetonide) for children aged 2-5 years old for the...

More...

New Drug Applications

PT. RICHMOND, Calif., Oct. 1 /PRNewswire/ -- Transcept Pharmaceuticals, Inc., a privately-held specialty pharmaceutical company, announced today that it has submitted a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA) for...
HUDDINGE, Sweden, Oct. 1, 2008-Medivir has today submitted an NDA to the US Food & Drug Administration (FDA) for Lipsovir, a topical product for prevention and treatment of cold sores. Lipsovir is a patented combination of hydrocortisone (an...
CHICAGO, Oct. 1 /PRNewswire-FirstCall/ -- Advanced Life Sciences Holdings, Inc. today announced the submission of a new drug application (NDA) for cethromycin in mild-to-moderate community acquired pneumonia (CAP). Advanced Life Sciences also...
TOKYO and INDIANAPOLIS, Sept. 26 /PRNewswire-FirstCall/ -- Daiichi Sankyo Company, Limited, and Eli Lilly and Company confirmed today that the U.S. Food and Drug Administration (FDA) did not complete its review for the prasugrel new drug application...
LEXINGTON, Mass., September 26, 2008 /PRNewswire-FirstCall/ -- Indevus Pharmaceuticals, Inc. announced today that it has reached agreement with the U.S. Food and Drug Administration (FDA) with regard to the additional data and risk management...

More...

Clinical Trials

"Peripheral Blood Mononuclear Cells Engineered with mRNA Encoding Chimeric Tumor Antigen Receptor for Cancer Therapy" AND "Use of Platelets as Therapeutic Delivery Vehicles" GAITHERSBURG, Md., Oct. 3 /PRNewswire-USNewswire/ -- MaxCyte, Inc., a...
BETHESDA, Md., Oct. 3, 2008-A single injection of carboplatin – a chemotherapy drug commonly used to treat ovarian and lung cancer – can replace radiotherapy to cure a common type of testicular cancer, according to results presented at...
ECLIPSE Data Published in Anesthesia and Analgesia FOR U.S. AUDIENCES ONLY PARSIPPANY, N.J., Oct. 3, 2008--(BUSINESS WIRE)--The Medicines Company (NASDAQ: MDCO) today announced that ECLIPSE, the largest safety program to date comparing...
SYDNEY, Australia, Oct. 3 /Xinhua-PRNewswire-FirstCall/ -- Pharmaceutical company Pharmaxis has announced that researchers will present 12 abstracts from its respiratory disease program at the 2008 European Respiratory Society Congress (ERS) being...
PV-10 Treatment for Metastatic Melanoma Well-Tolerated by Patients Evidence of “Bystander Effect” Observed in Phase 1 Trial KNOXVILLE, Tenn., Oct. 2, 2008--(BUSINESS WIRE)--Provectus Pharmaceuticals, Inc. (OTC BB: PVCT), a...

More...

More News Resources


MedNotes
Latest FDA Drug Alerts
October 3, 2008
Audience: Healthcare professionals, consumers [Posted 10/03/2008] FDA notified healthcare professionals of a Class I Recall of...
October 2, 2008
Audience: Physical medicine and rehabilitation specialists, anesthesia healthcare professionals, hospital surgical service...
September 30, 2008
Audience: Neurologists, cardiologists, consumers[Posted 09/30/2008] An FDA analysis provides new evidence that the use of statins...
September 26, 2008
Audience: Neurological healthcare professionalsPosted 09/23/2008] FDA has been made aware of preliminary safety findings from a...
More...
Latest Drug Information Updates

AdreView
AdreView is a diagnostic radiopharmaceutical agent indicated for use in the detection of rare neuroendocrine tumors in children and adults.

Sancuso
Sancuso (granisetron transdermal system) is an anti-emetic transdermal delivery system indicated for the control of nausea and vomiting in patients receiving moderately and/or highly nausea-inducing chemotherapy.

Nplate
Nplate (romiplostim) is a thrombopoietin mimetic peptibody for the treatment of thrombocytopenia in adult patients with chronic immune (idiopathic) thrombocytopenic purpura (ITP).

Xenazine
Xenazine (tetrabenazine) is a selective and reversible centrally-acting dopamine depleting drug indicated for the treatment of chorea associated with Huntington's disease.

Cleviprex
Cleviprex is an intravenous, ultrashort-acting calcium channel blocker under development for the treatment of severely elevated blood pressure in the hospital setting when oral therapy is not feasible or desirable.

Stavzor
Stavzor is delayed-release valproic acid formulated in the EnteriCare enteric soft gelatin capsule delivery system designed to minimize GI adverse events. Stavzor is indicated for the treatment of manic episodes associated with bipolar disorder, adjunctive therapy in multiple seizure types (including epilepsy), and prophylaxis of migraine headaches.

Navstel
Navstel is a balanced salt ophthalmic solution for use as an intraocular irrigation during surgical procedures involving perfusion of the eye.

Eovist
Eovist (gadoxetate disodium) is a gadolinium-based contrast agent for intravenous use in T1-weighted magnetic resonance imaging (MRI) of the liver to detect and characterize lesions in adults with known or suspected focal liver disease.

Evolence
Evolence is a collagen-based structural dermal filler for the correction of moderate to deep facial wrinkles and folds, such as nasolabial folds.

Kinrix
Kinrix [Diphtheria and Tetanus Toxoids and Acellular Pertussis Adsorbed and Inactivated Poliovirus Vaccine] is a combination vaccine for protection against diphtheria, tetanus, pertussis and polio diseases in children.

Durezol
Durezol (difluprednate ophthalmic emulsion) is a topical steroid for the treatment of postoperative ocular inflammation and pain.

PrandiMet
PrandiMet (repaglinide and metformin HCl) is a fixed-dose combination of the fast-acting secretagogue replaglinide (also known as Prandin) and insulin sensitizer, metformin, indicated for the treatment of type 2 diabetes.

Pentacel
Pentacel is a combination vaccine indicated for active immunization against diphtheria, tetanus, pertussis, poliomyelitis and invasive disease due to Haemophilus influenzae type b in children 6 weeks through 4 years of age.

Trivaris
Trivaris (triamcinolone acetonide) is a glucocorticoid corticosteroid delivered via intravitreal injection for the treatment of sympathetic ophthalmia, temporal arteritis, uveitis, and ocular inflammatory conditions unresponsive to topical corticosteroids.

Entereg
Entereg (alvimopan) is a peripherally-acting mu opioid receptor antagonist used to help patients regain gastrointestinal (GI) function earlier following bowel resection surgery.

More...